BRICS calls for fair and equitable distribution of Kovid-19 vaccines – India News

BRICS calls for fair and equitable distribution of Kovid-19 vaccines – India News

Further proposed by the WTO to waive patent protection by India and South Africa for the Kovid-19 vaccines, Brazil-Russia-India-China-South Africa (BRICS) group, saying that it “works for fair, equitable and affordable” Will do. ” Distribution of vaccines.

During the BRICS summit on Tuesday, Prime Minister Narendra Modi called for a group to withdraw the move of India and South Africa to secure exemption from intellectual property agreements for vaccines. The proposal is already facing opposition from developed countries, including the US and European Union (EU) member nations.

The Trade-Related Aspects of the World Trade Organization (WTO) of the World Trade Organization (WTO) is expected to take up the proposal for a patent protection exemption on Friday.

The Moscow Declaration adopted at the conclusion of the BRICS summit states that members of the group will “work to ensure that, when [the vaccine is] Available, it is broadcast on a fair, equitable and affordable basis. The declaration made no direct reference to the proposal of India and South Africa.

The declaration recognized the importance of “comprehensive vaccination” to prevent, prevent and prevent the transmission of coronaviruses, and supported a cooperative approach to accelerate the research, development and production of vaccines and treatments.

Participating in an online discussion on Tuesday, Foreign Minister S Jaishankar said that India will do everything possible to make vaccines affordable and accessible to people around the world.

The proposal submitted to the TRIPS Council by India and South Africa on 2 October stated that “it is important for WTO members to work together to ensure that intellectual property rights such as patents, industrial design, copyright and undisclosed Protection of information should not create barriers. Timely access to affordable medical products including vaccines and medicines or to increase research, development, manufacturing and supply of medical products needed to counter Kovid-19 ”.

The proposal further stated, “As new diagnostics, therapeutics and vaccines have been developed for Kovid-19, there are significant concerns as to how these will be made available in sufficient quantities and at affordable prices to meet global demand.” ” Difficulties in using flexibility under TRIPS.

Among the BRICS states, Russia has approved a vaccine, although experts say it has been done without adequate testing, and China has given emergency approval to three vaccines, one of which is for military personnel only. There are three vaccines in India that are under human trials.

Despite the current tensions in India-China relations, Chinese President Xi Jinping also offered to work with India on vaccines during the BRICS summit. “Chinese companies are working with their Russian and Brazilian partners on Phase III clinical trials of the vaccine and we are ready to collaborate with South Africa and India as well,” he said.

Developing countries are exploring India’s extensive vaccine manufacturing and distribution capabilities to help and the government held a special briefing for the Diplomatic Corps on 6 November to discuss potential cooperation on vaccines.


Leave a Reply

Your email address will not be published. Required fields are marked *